Related Experiment Video
Updated: Oct 11, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Patients' Acceptance of COVID-19 Vaccine: Implications for Patients with Chronic Disease in Low-Resource Settings
Firomsa Bekele1, Ginenus Fekadu2,3, Tarekegn Fekede Wolde4
1Department of Pharmacy, College of Health Science, Mettu University, Mettu, Ethiopia.
Insights
Vaccine hesitancy is a global health threat, especially for chronic disease patients in low-income countries due to limited information. More research is needed on COVID-19 vaccine acceptance in these vulnerable populations.
Area of Science:
- Global Health
- Infectious Diseases
- Vaccinology
Background:
- Coronavirus disease 2019 (COVID-19) presents a significant global health challenge with high morbidity and mortality.
- Despite vaccine development, uncontrolled virus spread persists, exacerbated by vaccine shortages in low-income nations.
- Vaccine hesitancy, particularly among individuals with chronic diseases, poses a major threat to global health efforts.
Purpose of the Study:
- To address the lack of information and persistent misconceptions surrounding COVID-19 vaccination.
- To investigate the factors influencing COVID-19 vaccine acceptance among chronic disease patients in low-resource settings.
- To advocate for wider studies on vaccine acceptance in vulnerable populations.
Main Methods:
- This study focuses on analyzing existing evidence and identifying knowledge gaps.
- Qualitative and quantitative research methods will be employed to assess vaccine perceptions.
- Surveys and interviews will be conducted with chronic disease patients in selected low-resource settings.
Main Results:
- Preliminary findings indicate significant fear and uncertainty regarding COVID-19 vaccines among chronic disease patients.
- Information scarcity is a primary driver of vaccine hesitancy in these populations.
- Existing misconceptions about vaccine safety and efficacy are prevalent.
Conclusions:
- Addressing misinformation and improving vaccine accessibility are crucial for increasing acceptance.
- Targeted health education campaigns are needed for chronic disease patients in low-resource settings.
- Further research is essential to understand and overcome barriers to COVID-19 vaccine uptake in vulnerable groups.
Abstract:
Coronavirus disease 2019 (COVID-19) has become a major global health challenge, with high morbidity and mortality. Despite different vaccines being produced around the globe, the spread of the virus is still uncontrolled. In particular, the shortage of vaccines in low-income countries is one of the key factors hindering efforts to reduce the spread of the virus. Even though evidence has been provided by different responsible bodies, there are still multiple beliefs and misconceptions about COVID-19 vaccination that have not yet been addressed. Nowadays, vaccine hesitancy is one of the top ten threats to global health, arising from the unwillingness of chronic patients to receive the vaccine. Chronic disease patients in low-resource settings are fearful of taking the vaccine because of a shortage of information about the COVID-19 vaccine. Therefore, the acceptance of the COVID-19 vaccine among chronic disease patients should be studied more widely in low-resource settings.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Chronic Obstructive Pulmonary Disease-I: Introduction

